Triazolyl piperidine arginine vasopressin receptor modulators

Details Triazolyl piperidine arginine vasopressin receptor modulators Triazolyl piperidine arginine vasopressin receptor modulators

2004-12-10

2010-06-29

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S326000

Reexamination Certificate

active

07745630

ABSTRACT:
Compounds of formula (I),or pharmaceutically acceptable derivatives thereof, wherein:Z, O, A, V, Y and Y′ are as defined herein; are useful for treating dysmenorreah.

REFERENCES:
patent: 4481360 (1984-11-01), Gall et al.
patent: 2007/0219187 (2007-09-01), Bessis et al.
patent: 0335144 (1989-10-01), None
patent: 1293503 (2003-03-01), None
patent: 1 293 503 (2003-09-01), None
patent: WO 01/58880 (2001-08-01), None
patent: WO 0158880 (2001-08-01), None
patent: WO 01/87855 (2001-11-01), None
patent: WO 02066149 (2002-08-01), None
patent: WO 02088108 (2002-11-01), None
patent: WO 03053437 (2003-07-01), None
patent: WO 03104207 (2003-12-01), None
patent: WO 2004021984 (2004-03-01), None
patent: WO 2004037809 (2004-05-01), None
patent: WO 2004074291 (2004-09-01), None
patent: WO 2005028452 (2005-03-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface p. 1-15.
Matthews et. al. “Synthesis and Biological Evaluation of Novel Indoloazepine Derivatives as Non-peptide Vasopressin V2 Receptor Antagonists.” Bioorganic & Medicinal Chemistry Letters 13 (2003) 753-756.
Zhang et. al. “Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists” Bioorganic & Medicinal Chemistry Letters 14 (2004) 2987-2989.
Lemmens-Gruber et. al. “Drugs of the future: Review Vasopressin antagonists” Cellular and Molecular Life Sciences 63 (2006) 1766-1779.
Stefan Schaefer and Peter Kolkhof “Failure is an option: learning from unsuccessful proof-of-concept trials” Drug Discovery Today, vol. 13, Nos. 21/22 Nov. 2008, pp. 913-916.
Andres, et. al. “Pharmacological characterization of F-180: a selective human V1a vasopressin receptor agonist of high affinity” British Journal of Pharmacology (2002) 135, 1828 -1836.
Francois Clemence, et al., “Synthèse et activité analgésique dans la série des triazoles-1,2,4”:European J. Med.—Chim. Ther., 1985-20, No. 3, pp. 257-266.
Kakefuda, Akio et al: “Discovery of 4,5-Dipnyl-1,2,4- triazole Derivatives as a Novel Class of Selective Antagonists for the Human VIA Receptor” Bioorganic & Medicinal Chemistry, 10(6), 1905-1912 CODEN: BMECEP; ISSN: 0968-0896, 2002, XP002281248 cited in the application table 1.
Kakefuda A et al: “Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4 phenyl-1,2,4- triazole derivatives as a novel class of selective antagonists for the human vasopressinV1A receptor” Journal of Medicinal and Pharmaceutical Chemisty, Americal Chemical Society Easton, US, vol. 45. No. 12, 2002, pp. 2589-2598, XP002237488 cited in the application table 1.
Clemence F. et al. “Synthese at active analgesique dans la serie des triazoles 1,2,4”, European Journal of Medicinal Chemistry, vol. 20, No. 3, 1985, pp. 257-266.
Kakefuda, A. et al., Discovery of 4,5-Diphenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human V1AReceptor, Bioorganic & Medicinal Chemistry 10 (2002) 1905-1912.
Kakefuda, A. et al., Synthesis and Pharmacological Evaluation of 5-(4-Biphenyl)3-methyl-4-phenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human Vasopressin V1aReceptor, J. Med. Chem. 2002, 45, 2589-2598.
WO 02/066149 takes the place of EP 1370349 which is the English equivalent to Chilean Applic. No. 237-2002.
WO 02/088108 takes the place of EP 1383759 which is the English equivalent to Chilean Applic. No. 897-2002.
WO 2004/021984 is the English equivalent of Chilean Applic. 1791-2003.
WO 2005/028452 is the equivalent to EP 1673355 which is the English equivalent to Chilean Applic. 2414-2004.

Affiliated with

Also associated with

Rating

Triazolyl piperidine arginine vasopressin receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolyl piperidine arginine vasopressin receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolyl piperidine arginine vasopressin receptor modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4171238